baber/WOPTO huggingface dataset:
Patent AT-E285427-T1 (AT)
Inventor: ENGBERT THEODOR
IPC: C08F299/06
Filed: 1999-04-12
Granted: 2005-01-15
Abstract: Composition comprises: (a) urethane (meth)acrylate, with (meth)acryloyl and optionally free isocyanate groups; (b) optionally a further polyisocyanate; (c) a radical polymerisation UV initiator; and (d) an aqueous binder containing active hydrogen. An Independent claim is also included for an urethane (meth)acrylate.
Patent AT-E225006-T1 (AT)
Inventor: SINTRAM ULF
IPC: F16D65/22
Filed: 1999-11-17
Granted: 2002-10-15
Abstract: A hydraulically-operated wheel brake cylinder (1) operates a brake shoe forming part of a hydraulic automotive drum brake. The brake has a housing (2) with first and second brake pistons (3, 4). The intermediate space (5) between the brake pistons (3, 4). The space (5) incorporates a mechanism (9) which adjusts the brake for mechanical wear step-by-step.
Patent AT-E215830-T1 (AT)
Inventor: BOON-FALLEUR THIERRY
IPC: C12N15/09
Filed: 1993-12-14
Granted: 2002-04-15
Abstract: The invention relates to complexes of human leukocyte antigen molecules and tyrosinase derived peptides SEQ ID NO: 2, on the surfaces of abnormal cells. The therapeutic and diagnostic ramifications of this observation are the subject of the invention.
Patent AT-E275494-T1 (AT)
Inventor: BIGO M JEAN
IPC: B62B7/00
Filed: 1999-06-14
Granted: 2004-09-15
Abstract: The pushchair has a reclinable hammock seat on a frame with pusher bars (15) that slide relative to front legs (11) when the pushchair is folded. The seat is joined to the frame by two sets of fixings, one of which (21) has adjusting mechanisms for the seat's angle, while the other set (19) co-operates with locking elements which ensure that the hammock is located in its set position each time the frame is unfolded. The locking elements consist of stops on the frame, at least one rod (114) to engage with a rear leg (13), and cams interacting with sliders (115).
Patent AT-E264981-T1 (AT)
Inventor: ANDERSSON LARS
IPC: E05F3/00
Filed: 1999-03-23
Granted: 2004-05-15
Abstract: The present invention relates to a device (1) in connection with mounting of a door closer (21), said door closer (21) being intended to actuate a door leaf (18) received in a frame (12). It is a frequent problem in connection with conventional door closers that the attachment of the door closer that is mounted in connection with the frame often loosens after a certain time of use of the door closer. The device according to the invention is characterized in that it comprises a mounting plate, an attachment (25) of the door closer being intended to be connected with said mounting plate, spacing means extending from said plate in a direction perpendicular to the plane of the plate (5) and means (11) to enable fastening of the spacing means in the frame (12).
Patent AT-E418730-T1 (AT)
Inventor: KIYOI HITOSHI
IPC: G01N33/50
Filed: 1999-08-19
Granted: 2009-01-15
Abstract: Investigation on the frequency of FLT3/ITD found in various blood cancers has revealed that the frequency is high in acute myeloblastic leukemia in particular. Studies on the effects of FLT3/ITD in the blood cell lines revealed that the tyrosine residues in FLT3/ITD is constitutively phosphorylated in these cell lines and that blood cells into which FLT3/ITD is introduced show IL-3 independent proliferation. Moreover, the blood cells into which FLT3/ITD is introduced are found to be capable of forming tumors and inhibit cell differentiation. The inventors have found that it is possible to screen for pharmaceutical compounds against tumors by using inhibition of these FLT3/ITD functions as an index.
Patent AT-E283292-T1 (AT)
Inventor: BURTON WILLIE C
IPC: C08F4/645
Filed: 1999-09-15
Granted: 2004-12-15
Abstract: A polyolefin elastomer possessing a unique combination of properties, i.e., high molecular weight (Mw), high Mooney viscosity (ML1+4 at 125° C.), low polydispersity index (Mw/Mn) and low glass transition temperature (Tg), is obtained by a polymerization process employing a particular type of a metallocene catalyst. The polyolefin elastomer is useful for manufacturing a variety of products including rubber articles such as hoses, belts and moldings, polymer blends containing one or more other hydrocarbon polymers and lubricating oils in which the elastomer functions as a viscosity modifier. Also disclosed is a cocatalyst for activating the metallocene procatalyst employing a specific molar ratio of the components of the cocatalyst to the transition metal of the procatalyst.
Patent AT-E317020-T1 (AT)
Inventor: MALLET JACQUES
IPC: C12N15/09
Filed: 1999-11-09
Granted: 2006-02-15
Abstract: The invention concerns novel compositions and methods for controlling nucleic acid expression in cells. More particularly, it concerns any nucleic acid characterised in that it comprises: a) a first region comprising a nucleic acid coding for a tetracycline (tTA)-dependent transactivator under the control of a moderate promoter; and b) a second region comprising a nucleic acid of interest under the control of tTA sensitive promoter. The invention is more particularly useful for controlling the expression of nucleic acids in the nerve cells, in vitro as well as in vivo, for example the human tyrosine hydrocyclosis.
Patent AT-E262267-T1 (AT)
Inventor: RONDEUX CHRISTIAN
IPC: G08C19/28
Filed: 1999-11-09
Granted: 2004-04-15
Abstract: The ionizing radiation command mechanism has an ionizing radiation generator (2) commanded by a command mechanism (1). The command link is established using a radio channel, using a transmitter code system.
Patent DE-1246413-T1 (DE)
Inventor: ROE EREZ
IPC: H04L12/56
Filed: 2002-03-15
Abstract: There is proposed a method of providing a signaling channel for performing one or more signaling functions at the level of Ethernet. The telecommunication of interest is organized by information packets forming an information flow, and the method comprises utilizing a combined flow composed from the information flow and one or more service flows formed from service packets being compatible with the information packets. The service packets belonging to a particular service flow carry indication of a corresponding one of the signaling functions to be performed, while the one or more service flows form the signaling channel at the level of Ethernet.
Patent DE-02447020-T1 (DE)
Inventor: STULENS ELS
IPC: A23L19/00
Filed: 2002-02-06
Abstract: The present invention is related to frozen fruits or frozen fruit pieces, especially strawberry or strawberry halves, coated with a powder layer able to avoid juice leaking from said fruits or fruit pieces and is related to the preparation process. <IMAGE>
Patent DE-02766404-T1 (DE)
Title: Verfahren zum Nachweis von genetischem Mosaizismus unter Verwendung von Arrays
Inventor: MOHAMMED MANSOOR
IPC: C12Q1/6886
Filed: 2002-09-27
Abstract: Verfahren
zum Nachweis eines genetischen Mosaizismus in einer Zellpopulation
durch Durchführen
einer Array-basierten, vergleichenden, genomischen Hybridisierung
(comparative genomic hybridization = CGH), das die folgenden Schritte
umfasst:  (a) Bereitstellen eines Arrays, der eine Vielzahl
von klonierten, genomischen Nukleinsäure-Segmenten umfasst, wobei jedes genomische
Nukleinsäure-Segment
an einem getrennten und bekannten Spot auf einer Substratoberfläche immobilisiert
ist, um einen Array zu bilden, und wobei die klonierten, genomischen
Nukleinsäure-Segmente
ein im wesentlichen vollständiges,
erstes Genom eines bekannten Karyotypen umfassen;  (b) Bereitstellen
einer ersten Probe, wobei die Probe eine Vielzahl genomischer Nukleinsäure-Segmente
umfasst, die ein im wesentlichen vollständiges Komplement des ersten
Genoms umfasst, markiert mit einem ersten, nachweisbaren Marker;  (c)
Bereitstellen einer zweiten Probe, wobei die Probe eine Vielzahl
genomischer Nukleinsäuren
umfasst, die mit einem zweiten, nachweisbaren Marker markiert sind,
und wobei die genomische Nukleinsäureprobe ein im wesentlichen
vollständiges
Komplement der genomischen Nukleinsäure einer Zelle oder einer
Gewebsprobe umfasst, und wobei der Karyotyp...
Patent DE-11180256-T1 (DE)
Title: Antennenstruktur mit Resonanzelementen und parasitären Elementen in Schlitzen der leitfähigen Elemente
Inventor: GUTERMAN JERZY
IPC: H01Q5/10
Filed: 2011-09-06
Abstract: Vorrichtung, aufweisend: ein leitendes Bauteil (12), das eine Öffnung (56) aufweist; zumindest zwei Antennenresonanzbauteile (60), die in der Öffnung (56) angeordnet sind; und ein parasitäres Antennenbauteil (60), das in der Öffnung angeordnet ist.
Patent DE-19752487-T1 (DE)
Title: System zur steuerung der achse einer digitalen pumpe
Inventor: CONSONNI GIORGIO MARIA
IPC: F04B49/06
Filed: 2019-08-08
Abstract: Digitales Pumpenachsensteuerungssystem (1) mit einer zumindest teilweise offenen Schaltung, umfassend:einen Elektromotor (10), der eine erste und eine zweite hydraulische Maschine (12, 14) antreibt, wobei die ersten und zweiten hydraulischen Maschinen (12, 14) drehfest miteinander verbunden sind;mindestens einen Zylinder (20) mit einer ersten Kammer (22a) und einer zweiten Kammer (22b), wobei die erste Kammer (22a) des Zylinders (20) über eine erste Rohrleitung (32) mit der ersten hydraulischen Maschine (12) und die zweite Kammer (22b) des Zylinders (20) über eine zweite Rohrleitung (34) mit der zweiten hydraulischen Maschine (14) verbunden ist;ein erstes Ventil (42), das in der ersten Rohrleitung (32) angeordnet ist;ein zweites Ventil (44), das in der zweiten Rohrleitung (34) angeordnet ist;ein drittes Ventil (46) in einer dritten Rohrleitung (36), wobei die dritte Rohrleitung (36) einen Teil der ersten Rohrleitung (32) zwischen der ersten hydraulischen Maschine (12) und dem ersten Ventil (42) und mit einem Teil der zweiten Rohrleitung (34) zwischen der zweiten hydraulischen Maschine (14) und dem zweiten Ventil (44) verbindet; undeinen offenen Tank (50) zum Bereitstellen von Hydraulikfluid an Einlässe der ersten und zweiten hydraulischen Maschinen (12, 14),dadurch gekennzeichnet, dassdie erste und die zweite Hydraulikmaschine (12, 14) digitale variable Verdrängungspumpen sind, die jeweils eine positive und eine negative Verdrängung von Hydraulikfluid bereitstellen, und wobei das dritte Ventil (46) es beiden Hydraulikmaschinen (12, 14) ermöglicht, an derselben Kammer (22a, 22b) des Zylinders (20) zusammenzuarbeiten.
Patent ES-2214168-T1 (ES)
Title: Derivados de acidos de azol sustituidos utiles como agentes antidiabeticos y contra la obesidad y procedimiento.
Inventor: CHENG PETER T
IPC: A61K31/403
Filed: 2002-05-23
Abstract: Un compuesto que tiene la estructura en la que m es 0, 1 ó 2; n = 0, 1 ó 2; Q es C o N A es (CH2)x donde x es de 1 a 5; o A es (CH2)x1, donde x1 es de 2 a 5, con un enlace alquenilo o un enlace alquinilo anclado en la cadena; o A es -(CH2)x2-O-(CH2)x3- en el que x2 es de 0 a 5 y x3 es de 0 a 5, de manera que al menos x2 o x3 sea distinto de cero. X1 es CH o N X2 es C, N, O o S; X3 es C, N, O o S; X4 es C, N, O o S; con la condición de que al menos uno de X2, X3 y X4 sea N; X5 es C, N, O o S; X6 es C o N; X7 es C, N, O o S; con la condición de que al menos X5, X6 o X7 sea N; y en donde cada uno de X1 a X7, como se definieron anteriormente C pueda incluir CH; R1 es H o alquilo; R2 es H, alquilo, alcoxi, halógeno, amino o amino sustituido. Y es CO2R4 (donde R4 es H o alquilo, o un éster profármaco) o Y es un 1-tetrazol unido a C, un ácido fosfínico de estructura P(O)(OR4a)R5, (donde R4a es H o un éster profármaco, R5 es alquilo o arilo) o un ácido fosfónico de estructura P(O)(OR4a)2; (CH2)x, (CH2)x1, (CH2)x2, (CH2)x3, (CH2)m y (CH2)n se pueden sustituir opcionalmente con 1, 2 ó 3 sustituyentes; incluyendo todos los estereoisómeros, un éster profármaco, y una sal farmacéuticamente aceptable del mismo.
Patent CY-1109317-T1 (CY)
Inventor: KOUROUNAKIS PANOS
IPC: C07D207/16
Filed: 2009-08-14
Abstract: Novel multifunctional compound for the treatment or the retardation of neurodegenerative diseases e.g. Alzheimer's disease and related pathological conditions. Formula (I); wherein, R is a non-steroidal anti-inflammatory drug moiety, being selected from the category of acetic acid derivatives (such as indomethacin), propionic acid derivatives (e.g. naproxen, ketoprofen) or various other acids with anti-inflammatory action which do not belong to the Above mentioned categories, A is a CHOH group or a CH<SUB>2</SUB> group or a (CH<SUB>2</SUB>)<SUB>2</SUB> group, Y is an antioxidant moiety (cysteamine or cysteine ethyl ester) or neuroprotective moiety (2-Pyridin-3-yl-alkanol) or NGF-inducing moiety (e.g. 2-methoxy-4-methyl-phenol).
Patent CY-1109685-T1 (CY)
Inventor: TANNER-BAUMGARTNER JESSICA
IPC: A61K47/26
Filed: 2009-12-14
Abstract: The present invention relates to novel therapeutic uses of iron(III) complex compounds with carbohydrates or derivatives thereof, in the preparation of a medicament for improving immune defense and/or brain performance.
Patent CY-1112504-T1 (CY)
Inventor: GAINEY CHARLES
IPC: G06F9/50
Filed: 2012-03-15
Abstract: In a logically partitioned host computer system comprising host processors (host CPUs) partitioned into a plurality of guest processors (guest CPUs) of a guest configuration, a perform topology function instruction is executed by a guest processor specifying a topology change of the guest configuration. The topology change preferably changes the polarization of guest CPUs, the polarization being related to the amount of a host CPU resource provided to a guest CPU.
Patent CY-1113753-T1 (CY)
Inventor: GRAY ANDREW
IPC: B62B5/04
Filed: 2012-08-23
Abstract: There is described a vehicle wheel assembly adapted to act as a power generator comprises a fixed body member and a rotatably mounted wheel member; characterised in that one of the body member and the wheel member is provided with a stator (25) and the other member is provided with a plurality of permanent magnets (23) which are of alternating polarity.
Patent CY-1113542-T1 (CY)
Title: Υδροξυβενζοϊκα αλατα μετανικοτινικων ενωσεων
Inventor: MUNOZ JULIO A
IPC: A61P25/00
Filed: 2013-01-14
Abstract: H p-υδροξυβενζοϊκή (2S)-(4E)-N-μεθυλ-5-(5-ισοπροποξυ-3-πυριδινυλ)-4-πεντεν-2-αμίνη και μια φαρμακευτική σύνθεση που περιλαμβάνει αυτή την ένωση.
Patent CY-1114173-T1 (CY)
Title: Α-γαλακτοζιδαση απο bifidobacterium bifidum και η χρηση της
Inventor: TZORTZIS GEORGIOS
IPC: A23L33/00
Filed: 2013-07-29
Abstract: Η παρούσα εφεύρεση αναφέρεται σε νέα α-γαλακτοζιδάση με δραστικότητα trans-γαλακτοζυλίωσης η οποία απομονώνεται από bifidobacterium bifidum. Η α-γαλακτοζιδάση είναι ικανή να μετατρέπει τη μελλιβιόζη σε δισακχαρίτες α-γαλακτοβιόζης οι οποίοι μπορούν να ενσωματωθούν σε πολυάριθμα τρόφιμα ή ζωοτροφές για τη βελτίωση της υγιεινής του εντέρου με προαγωγή της ανάπτυξης δισχιδών βακτηρίων εντός του εντέρου, και με καταστολή της ανάπτυξης της παθογόνου μικροχλωρίδας.
Patent CY-1115905-T1 (CY)
Title: Συσκευη εφαρμογης ρευστων
Inventor: KOROGI TODD M
IPC: A47L13/00
Filed: 2014-12-19
Abstract: Παρέχεται μια συσκευή εφαρμογής (14) για την εφαρμογή ενός ρευστού. Η συσκευή εφαρμογής μπορεί να περιλαμβάνει μιαν χειρολαβή. Η χειρολαβή μπορεί να αποτελείται από ένα επίμηκες κοίλο σώμα (16) έχον ένα άμεσο άκρο και ένα περιφερικό άκρο και τουλάχιστον μιαν επιμήκη, εσωτερική νεύρωση διακείμενη επί μιας εσωτερικής επιφάνειας ενός εξωτερικού τοιχώματος του κοίλου σώματος και διαμορφωμένη για τον προσανατολισμό και την καθοδήγηση ενός δοχείου (12) για να εμπεριέχει το ρευστό όταν το δοχείο διάκειται εντός του κοίλου σώματος. Επιπροσθέτως, η συσκευή εφαρμογής μπορεί να περιλαμβάνει μιαν βάση (22) στο περιφερικό άκρο του κοίλου σώματος. Περαιτέρω, η συσκευή εφαρμογής μπορεί να περιλαμβάνει και ένα πέλμα εφαρμογής (24) ζευγμένο στη βάση.
Patent CY-1117321-T1 (CY)
Title: Παρασκευη υδροχλωρικης ναλμεφενης απο ναλτρεξονη
Inventor: DE FAVERI CARLA
IPC: C07D489/08
Filed: 2016-02-17
Abstract: Μέθοδος για την παραγωγή υδροχλωρικής ναλμεφένης από ναλτρεξόνη, η οποία μέθοδος είναι ιδιαίτερα καλά προσαρμοσμένη για μεγάλης κλίμακας βιομηχανική εφαρμογή, και έχει ανακαλυφθεί ότι είναι αποτελεσματική, δίνει μια υψηλή απόδοση και προσφέρει πολύ καθαρό υδροχλωρικό άλας ναλμεφένης.
Patent CY-1119445-T1 (CY)
Title: Αντισωματα εναντι του ανθρωπινου gdf8
Inventor: STITT TREVOR
IPC: C07K16/22
Filed: 2017-10-11
Abstract: Η παρούσα εφεύρεση παρέχει μεμονωμένα ή εξανθρωπισμένα αντισώματα ή τμήματα αυτών που προσδένουν αντιγόνα τα οποία συνδέονται συγκεκριμένα με τον Παράγοντα και τον Παράγοντα Διαφοροποίησης-8 (GDF8) και αποκλείουν την δραστηριότητα του GDF8. Τα αντισώματα και τμήματα αντισωμάτων της παρούσας εφεύρεσης μπορούν να χρησιμοποιηθούν σε θεραπευτικές μεθόδους για την θεραπεία καταστάσεων ή διαταραχών που ανακουφίζονται ή βελτιώνονται με την αναστολή του GDF8.
Patent CY-1123650-T1 (CY)
Title: Μεθοδος για τη διαχειριση κατα εναν προσαρμοζομενο και κοινο τροπο της πολιτικης δρομολογησης και της πολιτικης επαναμεταδοσης ενος κομβου σε ενα υποθαλασσιο δικτυο
Inventor: PETRIOLI CHIARA
IPC: H04W40/02
Filed: 2020-02-17
Abstract: Η μέθοδος της εφεύρεσης προβλέπει τον προσδιορισμό, για κάθε πακέτο που πρόκειται να μεταδοθεί/επαναμεταδοθεί, μέσω ενός πρωτοκόλλου επικοινωνίας LLC, το οποίο είναι το άνω υπόστρωμα του στρώματος δικτύου ζεύξης δεδομένων του μοντέλου ISO-OSI, (λογική LLC) αυτόνομα, από κόμβο σε κόμβο, της συγκεκριμένης συσκευής επικοινωνίας που θα χρησιμοποιηθεί από αυτές που είναι διαθέσιμες στο μοναδικό κόμβο, προς το οποίο υποσύνολο κόμβων πρόκειται να μεταδοθεί το αναφερθέν πακέτο (λογική δρομολόγησης), δηλαδή του αριθμού και του συνόλου των γειτονικών κόμβων στους οποίους πρόκειται να μεταδοθεί, της συγκεκριμένης συσκευής επικοινωνίας που θα χρησιμοποιηθεί από αυτές που μπορεί να είναι διαθέσιμες, και του μέγιστου αριθμού επαναμεταδόσεων που θα γίνουν, χρησιμοποιώντας έναν αποκεντροποιημένο αλγόριθμο αυτοδιδασκαλίας που καθιστά δυνατό σε κάθε κόμβο να μαθαίνει και να επιλέγει δυναμικά τον καλύτερο τρόπο λειτουργίας, σύμφωνα με τον αριθμό των μεταδόσεων που έχουν ήδη γίνει.
Patent CY-1123065-T1 (CY)
Title: Ανασυνδυασμενα προβιοτικα βακτηριδια
Inventor: WIRTH THOMAS
IPC: A61K38/17
Filed: 2020-06-18
Abstract: Η εφεύρεση κατευθύνεται σε ανασυνδυασμένα προβιοτικά βακτηρίδια, ειδικώς για χρήση στη θεραπεία φλεγμονώδους δυσλειτουργίας του δέρματος, καθώς επίσης μέθοδο για θεραπεία φλεγμονώδους δυσλειτουργίας του δέρματος.
Patent HR-P20110535-T1 (HR)
Inventor: FEUERBACH DOMINIK
IPC: A61K31/439
Filed: 2011-07-18
Abstract: Spoj formule I naznačen time, daA	predstavlja O ili N(R1);Y	predstavlja skupinu formulepri čemu je lijeva veza priključena na skupinu A a desna veza je priključena na R skupinu; R	predstavlja C5-C10aril, koji je nesupstituiran ili je supstituiran s jednim ili više supstituenata odabranih iz skupine koju sačinjavaju amino, C1-C4alkil amino, di(C1-C4alkil)-amino, C3-C5cikloalkil amino, di(C3-C5)
Patent HR-P20110951-T1 (HR)
Title: Adhesive agent for application on a sanitary object
Inventor: LEIPOLD JOACHIM
IPC: C11D1/00
Filed: 2011-12-19
Abstract: Agent comprises fillers comprising a surfactant and a bonding agent comprising polyalkylene derivative, polyalkylene chains with statistically distributed functional groups, hydrogenated polystyrene derivatives, copolymers of monoalkyl esters of poly/methyl vinyl ether/carbonic acid anhydride, olefin homopolymers, and copolymers of two or more olefins, polyalkyleneimine in alkoxylated form, polyetheramine (alkoxylated amine), polyglycerin polyether alkyl carbonic acids or polymers or their derivatives comprising the polymer groups. Agent comprises fillers comprising a surfactant and a bonding agent comprising polyalkylene derivative, polyalkylene chains with statistically distributed functional groups, hydrogenated polystyrene derivatives, copolymers of monoalkyl esters of poly/methyl vinyl ether/carbonic acid anhydride, olefin homopolymers, and copolymers of two or more olefins, where the olefin homopolymers and copolymers are partially hydrogenated, partially oxidized, or further functionalized by graft molecules, polyalkyleneimine in alkoxylated form, polyetheramine (alkoxylated amine), polyglycerin polyether alkyl carbonic acids or polymers or their derivatives comprising the polymer groups, where: the viscosity of the agent is at least 30 Pas, measured using a Haake viscometer, plate/plate system, plate diameter of 10 mm at a shear rate of 2.62 seconds -> 1>at 20[deg] C; the concentration of surfactant in the bonding agent comprising polyalkyleneimine is 7-60 wt.%; and the agent is applied directly on the sanitary object and adhered, and is flushable only after a large number of flushes.
Patent SI-1294747-T1 (SI)
Title: Synthetic methods for aplidine and new antitumoral derivatives, methods of making and using them
Inventor: RODRIGUEZ IGNACIO
IPC: A61K38/00
Filed: 2001-07-02
Abstract: The invention relates to aplidine derivatives of the general formula: which are useful for the treatment of tumors.
Patent SI-2316439-T1 (SI)
Title: Abuse resistant opioid containing transdermal systems
Inventor: TAVARES LINO
IPC: A61M35/00
Filed: 2002-04-30
Abstract: The present invention relates to transdermal dosage form ( Fig. 1-3 ) comprising at least one activating agent and at least one inactivating agent. The dosage form ( Fig. 1-3 ) releases the inactivating agent upon disruption of the dosage form ( Fig. 1-3 ) thereby preventing or hindering misuse of the active agent contained in the dosage form ( Fig. 1-3 ).
Patent SI-1422095-T1 (SI)
Title: Window channel covering structure
Inventor: SCHABEL WOLFGANG
IPC: B60J10/75
Filed: 2003-11-06
Abstract: The window channel cover device for door windows of motor vehicles has a profiled window channel strip (6) and a window sealing element (8). A filling piece is fitted in a free space formed on the strip end side between the window panel sealing element and window channel strip. The filling piece is fastened to the window channel strip. The window channel strip has an end wall, with the filling piece fitting in the space between it and corresponding end of the window panel sealing element, and especially the latter's sealing lip arrangement.
Patent SI-1585810-T1 (SI)
Title: Method for culturing cells in order to produce substances
Inventor: LINK THOMAS
IPC: C12N5/071
Filed: 2003-11-07
Abstract: Culturing cells in order to produce substances, comprises setting a glucose limitation in the culture solution. Culturing cells in order to produce substances comprises setting a glucose limitation in the culture solution. The extent of glucose limitation (DGL) equals qGlc/Glc max, where qGlc is the current observed specific glucose consumption rate, and qGlc max is the maximum known glucose consumption rate for the cells in question. DGL lies between 0-1, where 0 is a complete limitation, and 1 represents no limitation (i.e. a complete glucose surplus). According to the invention the DGL is greater than or equal to the DGL that leads to the exclusive preservation of the cell and is 0.5.
Patent SI-1740204-T1 (SI)
Title: Medicinal use of alpha-mannosidase
Inventor: ANDERSSON CLAES
IPC: A61P25/00
Filed: 2005-04-01
Abstract: The present invention provides means and strategies for treating the lysosomal storage disorder alpha-mannosidosis by enzyme replacement therapy. In particular, the invention pertains to the reduction of stored neutral mannose-rich oligosaccharides in cells within the central nervous system. Accordingly, the present invention provides the use of a lysosomal alpha-mannosidase for the preparation of a medicament for reducing the intracellular levels of neutral mannose-rich oligosaccharides in cells within one or more regions of the central nervous system. The invention further provides a formulation of lysosomal alpha-mannosidase for use as a medicament for reducing the intracellular levels of neutral mannose-rich oligosaccharides in cells within one or more regions of the central nervous system. Also, the invention provides a method of reducing the intracellular levels of neutral mannose-rich oligosaccharides in cells within one or more regions of the central nervous system of a subject, said method comprising administering to said subject a preparation of lysosomal alpha-mannosidase. Finally, the invention pertains to methods of producing, isolating, and purifying an alpha-mannosidase as well as the use of an alpha-mannosidase, which is obtainable according to these methods.